Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid Arthritis

NCT01055899 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: REGN88
BIOLOGICAL: REGN88
BIOLOGICAL: REGN88

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]